Patent · US Active

FGF21 mimetic antibodies and uses thereof

US10899844B2 · kind B2 · utility

0Cited by
6References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2018
Grant dateJan 26, 2021
Priority date—
Expiry dateFeb 6, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.